{"id":"https://openalex.org/W2100004875","doi":"https://doi.org/10.1186/1742-4690-10-161","title":"Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells","display_name":"Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-01","ids":{"openalex":"https://openalex.org/W2100004875","doi":"https://doi.org/10.1186/1742-4690-10-161","mag":"2100004875","pmid":"https://pubmed.ncbi.nlm.nih.gov/24364896","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3877983"},"language":"en","primary_location":{"id":"doi:10.1186/1742-4690-10-161","doi":"https://doi.org/10.1186/1742-4690-10-161","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-10-161","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-10-161","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2100004875"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-10-161","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088644204","display_name":"Boghuma Kabisen Titanji","orcid":"https://orcid.org/0000-0002-6881-2764","observed_orcids":["https://orcid.org/0000-0002-6881-2764"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Boghuma Kabisen Titanji","raw_affiliation_strings":["Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","Division of Infection and Immunity University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Division of Infection and Immunity University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063795430","display_name":"Marl\u00e9n M. I. Aasa-Chapman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marlen Aasa-Chapman","raw_affiliation_strings":["Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","Division of Infection and Immunity University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Division of Infection and Immunity University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102813023","display_name":"Deenan Pillay","orcid":"https://orcid.org/0000-0003-2431-244X","observed_orcids":["https://orcid.org/0000-0003-2431-244X","https://orcid.org/0000-0003-3640-2573"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I95023434","display_name":"University of KwaZulu-Natal","ror":"https://ror.org/04qzfn040","country_code":"ZA","type":"education","lineage":["https://openalex.org/I95023434"]}],"countries":["GB","ZA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deenan Pillay","raw_affiliation_strings":["Africa Centre for Health and Population Sciences, University of KwaZulu Natal, KwaZulu-Natal, South Africa","Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","Division of Infection and Immunity, University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Africa Centre for Health and Population Sciences, University of KwaZulu Natal, KwaZulu-Natal, South Africa","institution_ids":["https://openalex.org/I95023434"]},{"raw_affiliation_string":"Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London, WC1E 6BT, United Kingdom","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Division of Infection and Immunity, University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083165031","display_name":"Clare L. Jolly","orcid":"https://orcid.org/0000-0002-4603-2281","observed_orcids":["https://orcid.org/0000-0002-4603-2281"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Clare Jolly","raw_affiliation_strings":["Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London WC1E 6BT, United Kingdom. c.jolly@ucl.ac.uk","Division of Infection and Immunity University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infection and Immunity, University College London, Cruciform Building, Gower St, London WC1E 6BT, United Kingdom. c.jolly@ucl.ac.uk","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Division of Infection and Immunity University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083165031"],"corresponding_institution_ids":["https://openalex.org/I45129253"],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":{"value":2890,"currency":"USD","value_usd":2890},"fwci":3.1289,"has_fulltext":true,"cited_by_count":87,"citation_normalized_percentile":{"value":0.9325863,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"161","last_page":"161"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cell-to-cell-spread","display_name":"cell-to-cell transmission","score":0.9319999814033508},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/lopinavir","display_name":"lopinavir","score":0.9599999785423279},{"id":"https://openalex.org/keywords/darunavir","display_name":"darunavir","score":1.0},{"id":"https://openalex.org/keywords/reverse-transcriptase-inhibitors","display_name":"reverse transcriptase inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/viral-reservoir","display_name":"viral reservoir","score":0.8309999704360962},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/multiplicity-of-infection","display_name":"multiplicity of infection","score":0.7839999794960022},{"id":"https://openalex.org/keywords/hiv-1-replication","display_name":"HIV-1 replication","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6498268842697144},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.5873833894729614},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5663265585899353},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.5360143184661865},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.5200647711753845},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.476749986410141},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.4700813591480255},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4589352309703827},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.4493733048439026},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43615293502807617},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.40671101212501526},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19447225332260132},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.1269625723361969},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08593836426734924},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.07454872131347656},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0734606385231018},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069454","descriptor_name":"Darunavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/1742-4690-10-161","doi":"https://doi.org/10.1186/1742-4690-10-161","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-10-161","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-10-161","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3877983","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3877983/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"Text"},{"id":"pmid:24364896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24364896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1417446","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1417446/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Retrovirology , 10 (1) , Article 161. (2013)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1186/1742-4690-10-161","doi":"https://doi.org/10.1186/1742-4690-10-161","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-10-161","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-10-161","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7110213575","display_name":"Collaborative HIV and Anti-HIV Drug Resistance Network","funder_award_id":"223131","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G7928729655","display_name":"Identifying regulators of HIV-1 cell-to-cell spread at virological synapses","funder_award_id":"MR/J008184/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2100004875.pdf","grobid_xml":"https://content.openalex.org/works/W2100004875.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1227234993","https://openalex.org/W1557952727","https://openalex.org/W1619221212","https://openalex.org/W1965166311","https://openalex.org/W1967398944","https://openalex.org/W1977929936","https://openalex.org/W1991187231","https://openalex.org/W1992366636","https://openalex.org/W1996684522","https://openalex.org/W2003812878","https://openalex.org/W2005141763","https://openalex.org/W2009898112","https://openalex.org/W2011518212","https://openalex.org/W2012065621","https://openalex.org/W2013711784","https://openalex.org/W2014005194","https://openalex.org/W2020422739","https://openalex.org/W2022876489","https://openalex.org/W2023467404","https://openalex.org/W2030541908","https://openalex.org/W2034611990","https://openalex.org/W2034996626","https://openalex.org/W2036645656","https://openalex.org/W2047385553","https://openalex.org/W2050173781","https://openalex.org/W2054614777","https://openalex.org/W2059564465","https://openalex.org/W2075291405","https://openalex.org/W2085782638","https://openalex.org/W2087615269","https://openalex.org/W2089692155","https://openalex.org/W2095703604","https://openalex.org/W2095828874","https://openalex.org/W2097912258","https://openalex.org/W2100298806","https://openalex.org/W2102239633","https://openalex.org/W2109590624","https://openalex.org/W2109604183","https://openalex.org/W2117057469","https://openalex.org/W2119974226","https://openalex.org/W2123193533","https://openalex.org/W2131981029","https://openalex.org/W2136958613","https://openalex.org/W2137870598","https://openalex.org/W2139167304","https://openalex.org/W2139552123","https://openalex.org/W2141264092","https://openalex.org/W2143666216","https://openalex.org/W2162571984","https://openalex.org/W2168251450","https://openalex.org/W2170463669"],"related_works":["https://openalex.org/W2584140774","https://openalex.org/W769574623","https://openalex.org/W2037789797","https://openalex.org/W1992366636","https://openalex.org/W2531321308","https://openalex.org/W2097912258","https://openalex.org/W1121829009","https://openalex.org/W2136958613"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"Human":[2],"Immunodeficiency":[3],"Virus":[4],"type-1":[5],"(HIV-1)":[6],"spreads":[7],"by":[8,12,180,252],"cell-free":[9,128],"diffusion":[10],"and":[11,102,121,129,149,185,193,241],"direct":[13],"cell-to-cell":[14,32,72,88,130,147,230],"transfer,":[15],"the":[16,40,82,109,118,158,181,189,200,206,214,223,253],"latter":[17],"being":[18],"a":[19,138],"significantly":[20],"more":[21,152,176],"efficient":[22],"mode":[23],"of":[24,42,62,68,74,85,90,112,132,160,171,191,202,209,216,226,233,243,265],"transmission.":[25],"Recently":[26],"it":[27],"has":[28],"been":[29],"suggested":[30],"that":[31,106,117,137,166,205,221],"spread":[33,89,131,148,170],"may":[34],"permit":[35],"ongoing":[36],"virus":[37,156,231],"replication":[38,240],"in":[39,99,157,196],"presence":[41,159],"antiretroviral":[43],"therapy":[44],"(ART)":[45],"based":[46],"on":[47,199,213,229,238],"studies":[48],"performed":[49],"using":[50],"Reverse":[51],"Transcriptase":[52],"Inhibitors":[53,56],"(RTIs).":[54],"Protease":[55],"(PIs)":[57],"constitute":[58],"an":[59],"important":[60],"component":[61],"ART;":[63],"however":[64],"whether":[65],"this":[66,246],"class":[67],"inhibitors":[69],"can":[70],"suppress":[71],"transfer":[73],"HIV-1":[75,91,113,172,234,266],"is":[76,150,173,211,247],"unexplored.":[77],"Here":[78],"we":[79,115,164],"have":[80],"evaluated":[81],"inhibitory":[83],"effect":[84],"PIs":[86,119,258],"during":[87,146],"between":[92],"T":[93,167],"lymphocytes.":[94],"RESULTS:":[95],"Using":[96],"quantitative":[97],"assays":[98],"cell":[100,104,169],"line":[101],"primary":[103],"systems":[105],"directly":[107],"measure":[108],"early":[110],"steps":[111],"infection":[114],"find":[116,165],"Lopinavir":[120],"Darunavir":[122],"are":[123],"equally":[124],"potent":[125],"against":[126,262],"both":[127,263],"HIV-1.":[133],"We":[134,219],"further":[135],"show":[136],"protease":[139],"resistant":[140,144,177],"mutant":[141],"maintains":[142],"its":[143],"phenotype":[145],"transmitted":[151],"efficiently":[153],"than":[154],"wild-type":[155],"drug.":[161],"By":[162],"contrast":[163],"cell-T":[168],"4-20":[174],"fold":[175],"to":[178,249],"inhibition":[179],"RTIs":[182],"Nevirapine,":[183],"Zidovudine":[184],"Tenofovir.":[186],"Notably,":[187],"varying":[188],"ratio":[190],"infected":[192],"uninfected":[194],"cells":[195],"co-culture":[197],"impacted":[198],"degree":[201],"inhibition,":[203],"indicating":[204],"relative":[207],"efficacy":[208],"ART":[210],"dependent":[212],"multiplicity":[215],"infection.":[217],"CONCLUSIONS:":[218],"conclude":[220],"if":[222],"variable":[224],"effects":[225],"antiviral":[227,254],"drugs":[228],"dissemination":[232],"do":[235],"indeed":[236],"impact":[237],"viral":[239,244],"maintenance":[242],"reservoirs":[245],"likely":[248],"be":[250],"influenced":[251],"drug":[255],"class,":[256],"since":[257],"appear":[259],"particularly":[260],"effective":[261],"modes":[264],"spread.":[267]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2100004875","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
